No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CVS CVS Health
- 59.000
- +0.790+1.36%
Close Jul 12 16:00 ET
- 58.900
- -0.100-0.17%
Post 19:58 ET
74.07BMarket Cap10.35P/E (TTM)
59.570High57.851Low8.22MVolume58.300Open58.210Pre Close484.19MTurnover0.66%Turnover Ratio9.12P/E (Static)1.26BShares81.70852wk High1.00P/B73.88BFloat Cap52.77152wk Low2.48Dividend TTM1.25BShs Float103.988Historical High4.20%Div YieldTTM2.95%Amplitude6.497Historical Low58.902Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CVS Health's Options Frenzy: What You Need to Know
Deep-pocketed investors have adopted a bearish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical
CVS Health Corporation's (NYSE:CVS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
FTC to Sue Pharmacy Benefit Managers Over Insulin Prices
By Liz Essley Whyte and Anna Wilde Mathews The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including
Comments
$CVS Health(CVS.US$ dividend opportunity. and soon cannibas dispensary services at the pharmacy.
$CVS Health(CVS.US$ No haste in putting your money on this sleeping giant now. Its time will come, but definitely not in the near time. Keep it on your tabs.
As the dust settles on the latest presidential debate, market analysts are scrutinizing the implications of a potential shift in the political landscape. With former President Donald Trump's support rate increasing post-debate, the healthcare sector is witnessing a surge in certain stocks. Biotech investors are eyeing a favorable environment ahead.
The probability of Trump reclaiming the Oval Office is now pegged at around 6...
The probability of Trump reclaiming the Oval Office is now pegged at around 6...
21
8
$Walgreens Boots Alliance(WBA.US$ looks like good value at current price BUT don’t forget we focus on how it’s trending in the future 📉
$CVS Health(CVS.US$
$CVS Health(CVS.US$
1
Jim Cramer highlighted several budget-friendly retail stocks that are thriving as consumers seek better prices amid inflation. ![]()
Cramer noted that while consumers aren't necessarily cash-strapped, they are fed up with high prices and are seeking bargains. He pointed to $Walmart(WMT.US$ and $Costco(COST.US$ , with their low-cost offerings, as particularly appealing. Walmart and Costco have risen 30% year to date, whereas $Walgreens Boots Alliance(WBA.US$ and ...
Cramer noted that while consumers aren't necessarily cash-strapped, they are fed up with high prices and are seeking bargains. He pointed to $Walmart(WMT.US$ and $Costco(COST.US$ , with their low-cost offerings, as particularly appealing. Walmart and Costco have risen 30% year to date, whereas $Walgreens Boots Alliance(WBA.US$ and ...
From YouTube
6
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
